Table 1 Preoperative characteristics of patients with suture placement on the lower gastrointestinal tract during source control surgery (SCS) for secondary peritonitis

Demographics

Male gender, n (%)

80 (57.1%)

31 (65.9%)

0.2871

Age, years (IQR)

61 (46–75)

63 (54–76)

0.2030

BMI, kg/m² (IQR)

25.1 (22–28.4)

26.2 (23.5–29.8)

0.1439

Underlying conditions

Chronic pulmonary disease, n (%)

29 (20.7%)

11 (23.4%)

0.6972

Malignancy, n (%)

51 (36.4%)

23 (48.9%)

0.1292

Chronic liver disease, n (%)

10 (7.1%)

5 (10.6%)

0.4453

Chronic kidney disease, n (%)

32 (22.8%)

12 (25.5%)

0.7084

Cardio-vascular disease, n (%)

54 (38.5%)

18 (38.3%)

0.9734

Diabetes, n (%)

27 (19.3%)

10 (21.3%)

0.7669

Chronic inflammatory disease, n (%)

21 (15.4%)

6 (12.2%)

0.5869

Previous medication

Therapeutic anticoagulation, n (%)

28 (20.0%)

11 (23.4%)

0.6192

Platelet aggregation inhibitors, n (%)

43 (30.7%)

14 (29.8%)

0.9049

Chronic steroid therapy, n (%)

21 (15.0%)

4 (8.5%)

0.2580

Chemotherapy within last 3 months, n (%)

12 (8.5%)

4 (8.5%)

0.9897

Immunosuppressants, n (%)

9 (6.4%)

2 (4.2%)

0.5838

Statins, n (%)

35 (25.0%)

9 (19.1%)

0.4132

Lifestyle risk factors

Malnutrition (BMI < 20), n (%)

19 (13.5%)

5 (10.6%)

0.6029

Obesity (BMI ≥ 30), n (%)

31 (22.1%)

15 (31.9%)

0.1783

Preoperative laboratory parameters

Leukocytes, 10⁹/L (IQR)

13.55 (9.3–19.3)

10.5 (7.4–17.9)

0.0541

Hb, g/L (IQR)

106 (92–127)

104 (91–123)

0.4377

CRP, mg/L (IQR)

173.1 (64.8–252.6)

215.4 (150.9–306.7)

0.0324

sCHE, kU/L (IQR)

4.5 (2.8–6.2)

3.3 (1.8–4.7)

0.0029

Creatinine, mg/dL (IQR)

0.9 (0.7–1.4)

0.9 (0.7–1.7)

0.3875

Bilirubin, mg/dL (IQR)

0.6 (0.3–0.9)

0.8 (0.4–1.5)

0.0281

Platelet count, 10⁹/L (IQR)

277 (215.3–387.3)

250 (192–308)

0.0802

ASA score, (IQR)

3 (3–3)

3 (3–3)

0.4334